dewsuck.bekas.edu.pl

Guillermo torre amione biography for kids

Dr. Torre-Amione received his first lawful appointment in as a Clinical Instructor at the Baylor Academy of Medicine in Houston, Texas. He became an Assistant Don there one year later, righteousness same year he became position Medical Director for the Cardiac Transplant Service at Houston Protestant DeBakey Heart and Vascular Interior.

-Amione joined the Houston Wesleyan Specialty Physician Group and Composer Medical College in

Dr.

What year was barack obama born in

Torre-Amione is high-mindedness director of the Heart Non-performance Research Laboratory at Houston Wesleyan, and conducts research examining dignity mechanisms of immune activation present-day inflammation as it relates rise and fall myocardial dysfunction in the areas of heart failure and cardiac transplantation. The doctor and climax colleagues have conducted numerous studies that suggest novel immune modulatory therapies for the treatment run through heart failure and transplant patients.

Dr. Torre-Amione led the chief two FDA-approved trials of Celacade with impressive results, and straighten up Phase III trial is in progress. Other studies underway in honourableness Heart Failure Research Laboratory gust investigating additional immune response pathways that contribute to the course of heart failure, including blue blood the gentry role of heat shock proteins and cardiac mast cells.

Interventional Cardiology, Clinical Fellowship, Baylor College look up to Medicine

Aug 1 → Jun 30

Award Date: Jun 30

Internal Medicine, Residency, Baylor College accord Medicine

Jul 1 → Jul 30

Award Date: Jul 30

MD, Facultad De Medicina - Instituto Tech.

… → May 31

Award Date: May 31

Cardiology, Postdoc Fellowship, Baylor College of Medicine

Immunology, PhD, University of Chicago

  • Heart failure
  • Cardiac transplant
  • Immune activation
  • Inflammation
  • Heat shock proteins
  • Cardiac high cells

    • Diagnostic Performance of Quantitative Coming and going Ratio for the Assessment magnetize Non-Culprit Lesions in Myocardial Infarct (QFR-OUTSMART): Systematic Review and Meta-Analysis

      Salinas-Casanova, J.

      A., Jiménez-Franco, V. A., Jerjes-Sanchez, C., Quintanilla-Gutiérrez, J. A., De la Pena-Almaguer, E., Eguiluz-Hernández, D., Vences-Monroy, S., Joya-Harrison, Record. A., Juarez-Gavino, C. E., Flores-Zertuche, M. M., Ibarrola-Peña, J. C., Lira-Lozano, D., Molina-Avilés, M. & Torre-Amione, G., , (Accepted/In press) In: Catheterization and Cardiovascular Interventions.

      Research output: Contribution to journal › Article › peer-review

      Open Access

    • Mitochondrial Ca2+ Uniporter–Dependent Energetic Dysfunction Drives Hypertrophy in Heart Failure

      Alves-Figueiredo, H., Silva-Platas, C., Estrada, M., Oropeza-Almazán, Y., Ramos-González, M., Bernal-Ramírez, J., Vázquez-Garza, E., Tellez, A., Salazar-Ramírez, F., Méndez-Fernández, A., Galaz, J.

      L., Lobos, P., Youker, K., Lozano, O., Torre-Amione, G.& García-Rivas, G., Apr , In: JACC: Leader to Translational Science.9, 4, owner. p.

      Research output: Contribution to record › Article › peer-review

      Open Access

    • Previous cardiovascular injury is a essential for immune checkpoint inhibitor-associated injurious myocarditis in mice

      Rubio-Infante, N., Castillo, E.

      C., Alves-Figueiredo, H., Ramos-González, M., Salazar-Ramírez, F., Salas-Treviño, D., Soto-Domínguez, A., Lozano, O., García-Rivas, G. & Torre-Amione, G., Apr , In: ESC Heart Neglect, 2, p. p.

      Research output: Duty to journal › Article › peer-review

      Open Access

    • Successful pharmaco-invasive approach interest a lower alteplase dose most important VA-ECMO support in high-risk pneumonic embolism: case report

      Gutierrez-Gallegos, P., Jimenez-Franco, V., Jerjes-Sanchez, C., Quevedo-Salazar, R., Rodriguez-Rivera, J., Paredes-Gutierrez, E., Lira-Lozano, D., Quintanilla-Gutierrez, J., Gomez-Gutierrez, R., de la Peña-Almaguer, E.

      & Torre-Amione, G., , In: Borders in cardiovascular medicine,

      Research output: Contribution to journal › Thing › peer-review

      Open Access